Visualization of specific B and T lymphocyte interactions in the lymph node

Science

Volumn 281, Issue 5373, 1998, Pages 96-99

  Garside, Paul ^a   Ingulli, Elizabeth ^b   Merica, Rebecca R ^b   Johnson, Julia G ^b   Noelle, Randolph J ^c   Jenkins, Marc K ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39; LYSOZYME; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNIZATION; LYMPH FOLLICLE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL MOVEMENT; DENDRITIC CELLS; GERMINAL CENTER; IMMUNIZATION; IMMUNOGLOBULIN M; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PLASMA CELLS;

ANIMALIA; MUS MUSCULUS;

EID: 0032479526     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5373.96     Document Type: Article

References (36)

1. N. A. Mitchison, Eur. J. Immunol. 1, 18 (1971); M. C. Raff, Nature 226, 1257 (1970); E. S. Vitetta, B. R. Fernandez, C. D. Myers, V. M. Sanders, Adv. Immunol. 45, 1 (1989).
2. N. A. Mitchison, Eur. J. Immunol. 1, 18 (1971); M. C. Raff, Nature 226, 1257 (1970); E. S. Vitetta, B. R. Fernandez, C. D. Myers, V. M. Sanders, Adv. Immunol. 45, 1 (1989).
3. N. A. Mitchison, Eur. J. Immunol. 1, 18 (1971); M. C. Raff, Nature 226, 1257 (1970); E. S. Vitetta, B. R. Fernandez, C. D. Myers, V. M. Sanders, Adv. Immunol. 45, 1 (1989).
4. A. Lanzavecchia, Nature 314, 537 (1985).
5. H. Kupfer, C. R. Monks, A. Kupfer, J. Exp. Med. 179, 1507 (1994); E. A. Clark and J. A. Ledbetter, Nature 367, 425 (1994).
6. H. Kupfer, C. R. Monks, A. Kupfer, J. Exp. Med. 179, 1507 (1994); E. A. Clark and J. A. Ledbetter, Nature 367, 425 (1994).
7. C. Kelsoe, Immunity 4, 107 (1996); I. C. MacLennan et al., Immunol. Rev. 156, 53 (1997).
8. C. Kelsoe, Immunity 4, 107 (1996); I. C. MacLennan et al., Immunol. Rev. 156, 53 (1997).
9. high) and were clearly capable of undergoing extensive clonal expansion in vivo after adoptive transfer and immunization (Fig. 1).
10. K. M. Murphy, A. B. Heimberger, D. Y. Loh, Science 250, 1720 (1990).
11. C. C. Goodnow et al., Nature 334, 676 (1988).
12. 1 recipients.
13. K. Haskins et al., J. Exp. Med. 157, 1149 (1983).
14. a+ MD4 B cells increased to 8.0 and 8.8%, respectively, 5 days after immunization with cOVA-HEL (11).
15. a+ MD4 B cells as described in (8).
16. T. M. Foy, A. Aruffo, J. Bajorath, J. E. Buhlmann, R. J. Noelle, Annu. Rev. Immunol. 14, 591 (1996).
17. P. Garside, unpublished data.
18. E. R. Kearney, K. A. Pape, D. Y. Loh, M. K. Jenkins, Immunity 1, 327 (1994).
19. B. Zheng, S. Man, G. Kelsoe, J. Exp. Med. 184, 1083 (1996); K. A. Fuller, O. Kanagawa, M. H. Nahm, J. Immunol. 151, 4505 (1993); A. Gulbranson-Judge and I. MacLennan, Eur. J. Immunol. 26, 1830 (1996).
20. B. Zheng, S. Man, G. Kelsoe, J. Exp. Med. 184, 1083 (1996); K. A. Fuller, O. Kanagawa, M. H. Nahm, J. Immunol. 151, 4505 (1993); A. Gulbranson-Judge and I. MacLennan, Eur. J. Immunol. 26, 1830 (1996).
21. B. Zheng, S. Man, G. Kelsoe, J. Exp. Med. 184, 1083 (1996); K. A. Fuller, O. Kanagawa, M. H. Nahm, J. Immunol. 151, 4505 (1993); A. Gulbranson-Judge and I. MacLennan, Eur. J. Immunol. 26, 1830 (1996).
22. S. A. Luther, A. Gulbranson-Judge, H. Acha-Orbea, I. C. M. MacLennan, J. Exp. Med. 185, 551 (1997).
23. E. Ingulli, A. Mondino, A. Khoruts, M. K. Jenkins, ibid., p. 2133.
24. J. Braun, P. S. Hochman, E. R. Unanue, J. Immunol. 128, 1198 (1982).
25. E. E. Eynon and D. C. Parker, J. Exp. Med. 175, 131 (1992); E. J. Fuchs and P. Matzinger, Science 258, 1156 (1992).
26. E. E. Eynon and D. C. Parker, J. Exp. Med. 175, 131 (1992); E. J. Fuchs and P. Matzinger, Science 258, 1156 (1992).
27. J. Jacob, R. Kassir, G. Kelsoe, J. Exp. Med. 173, 1165 (1991).
28. W. J. Liu, J. Zhang, P. J. L. Lane, E. Y. T. Chan, I. C. M. MacLennan, Eur. J. Immunol. 21, 2951 (1991); J. G. Cyster and C. C. Goodnow, Immunity 3, 691 (1995).
29. W. J. Liu, J. Zhang, P. J. L. Lane, E. Y. T. Chan, I. C. M. MacLennan, Eur. J. Immunol. 21, 2951 (1991); J. G. Cyster and C. C. Goodnow, Immunity 3, 691 (1995).
30. J. Jacob and G. Kelsoe, J. Exp. Med. 176, 679 (1992).
31. K. A. Vora, K. M. Tumas-Brundage, T. Manser, J. Immunol. 160, 728 (1998).
32. M. K. Slifka, R. Antia, J. K. Whitmire, R. Ahmed, Immunity 8, 363 (1998).
33. R. Shimonkevitz, J. Kappler, P. Marrack, H. Grey, J. Exp. Med. 158, 303 (1983).
34. C. P. Liu, J. W. Kappler, P. Marrack, ibid. 184, 1619 (1996).
35. a staining mentioned in (70) was not detected on tissue sections and thus has no bearing on the immunohistology experiments.
36. We thank J. Walter and M. Michels for technical assistance and T. Behrens, D. Mueller, M. Mescher, J. Cyster, and K. Hogquist for helpful discussions. Supported by grants from NIH (AI27998, AI35296, and AI39614 to M.K.J.; K08-AI01503 and HD33692 to E.I.; and AI07421 to R.R.M.), the University Children's Foundation (E.I.), the Vikings Children's Fund (E.I.), and the Wellcome Trust (P.C.).